Fresenius Medical Care AG & Co. KGaA (FMS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 13.81B |
| Enterprise value | 26.62B |
| Trailing P/E | 14.98 |
| Forward P/E | 11.00 |
| PEG ratio (5-yr expected) | 0.74 |
| Price/sales (ttm) | 0.73 |
| Price/book (mrq) | 0.99 |
| Enterprise value/revenue | 1.48 |
| Enterprise value/EBITDA | 7.71 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.98 |
| 52-week change 3 | -40.35% |
| S&P500 52-week change 3 | -8.83% |
| 52-week high 3 | 42.13 |
| 52-week low 3 | 23.29 |
| 50-day moving average 3 | 29.66 |
| 200-day moving average 3 | 32.37 |
Share statistics
| Avg vol (3-month) 3 | 576.24k |
| Avg vol (10-day) 3 | 1.11M |
| Shares outstanding 5 | 586.05M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 397.29M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 6.50% |
| Shares short (30 May 2022) 4 | 991.87k |
| Short ratio (30 May 2022) 4 | 2.1 |
| Short % of float (30 May 2022) 4 | N/A |
| Short % of shares outstanding (30 May 2022) 4 | 0.17% |
| Shares short (prior month 28 Apr 2022) 4 | 723.8k |
Dividends & splits
| Forward annual dividend rate 4 | 0.71 |
| Forward annual dividend yield 4 | 2.43% |
| Trailing annual dividend rate 3 | 1.34 |
| Trailing annual dividend yield 3 | 5.54% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 44.81% |
| Dividend date 3 | 26 May 2022 |
| Ex-dividend date 4 | 12 May 2022 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 03 Dec 2012 |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 4.89% |
| Operating margin (ttm) | 9.57% |
Management effectiveness
| Return on assets (ttm) | 3.16% |
| Return on equity (ttm) | 8.12% |
Income statement
| Revenue (ttm) | 17.96B |
| Revenue per share (ttm) | 30.65 |
| Quarterly revenue growth (yoy) | 8.00% |
| Gross profit (ttm) | 5.08B |
| EBITDA | 2.59B |
| Net income avi to common (ttm) | 877.72M |
| Diluted EPS (ttm) | 1.57 |
| Quarterly earnings growth (yoy) | -36.80% |
Balance sheet
| Total cash (mrq) | 1.17B |
| Total cash per share (mrq) | 2 |
| Total debt (mrq) | 13.34B |
| Total debt/equity (mrq) | 91.78 |
| Current ratio (mrq) | 1.26 |
| Book value per share (mrq) | 22.58 |
Cash flow statement
| Operating cash flow (ttm) | 2.44B |
| Levered free cash flow (ttm) | 1.34B |
© 2022 Yahoo. All rights reserved.
